Cyban Pty Ltd
Mary-Beth Brinson currently serves as the Chief Executive Officer of Cyban Pty Ltd and holds various prominent positions, including being a member of the International Women's Forum and an Adjunct Fellow at Macquarie University. Prior to Cyban, Mary-Beth founded DelfiClinic and was the Chief Medical Officer, Chief Executive Officer, and Interim Chief Executive Officer at TALi. Notably, Mary-Beth spent over 15 years at Cochlear, where key roles included Vice President Global Clinical Affairs and Director of Quality, Clinical, Research and Regulatory Services for the Asia Pacific region. Educational qualifications include an MBA from Rutgers University, a Bachelor's in Speech Pathology/Audiology from The University of Georgia, and a Doctorate in Audiology from the University of Louisville School of Medicine.
This person is not in the org chart
This person is not in any teams
Cyban Pty Ltd
Cyban’s next generation brain oxygen monitor delivers unprecedented brain health monitoring in a non-invasive manner. It enables reliable, early detection of brain hypoxia to help reduce mortality and disability, therefore reducing the need for invasive surgical procedures to provide accurate measurement of brain oxygen levels. Our patented technology uses a proprietary sensor design, novel signal processing and multi-functional capability to deliver reliable results from the site of trauma to hospital discharge. Through this technology Cyban is advancing the treatment of brain injuries by accelerating detection, diagnosis accuracy and treatment times.